HotCopper Corporate Spotlight: Interview with Bob Proulx, CEO Imagion Biosystems (ASX:IBX) discussing their medical imaging technology being designated by the FDA as a breakthrough device.
Positive independent review sets priority path to market for MagSense® Technology
Highlights Blinded review by panel of expert breast radiologists corroborates potential for MagSense® nanoparticle technology to detect tumour cells in lymph nodes by Magnetic Resonance